Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Apr 4;15(4):e247852.
doi: 10.1136/bcr-2021-247852.

Marchiafava-Bignami disease presenting as reversible coma

Affiliations
Case Reports

Marchiafava-Bignami disease presenting as reversible coma

Yixin Zhang et al. BMJ Case Rep. .

Abstract

Marchiafava-Bignami disease (MBD) is a rare demyelinating condition of the corpus callosum and subcortical white matter that is most commonly seen in alcoholic patients. The course of the disease varies with symptoms that range from dementia to complete coma; severe intermittent sympathetic storming with abnormal posturing is often reported in literature. It is presumably secondary to a deficiency of B complex vitamins, specifically thiamine and many patients have clinical improvement after repletion of B vitamins. We present a case of a 35-year-old man who developed MBD secondary to polysubstance misuse without history of alcohol use. His clinical course was complicated by persistent comatose state with autonomic dysfunction. After the administration of high-dose thiamine and vitamin C and E, the patient regained consciousness and was able to follow commands within 48 hours. Furthermore, this case showed recognising brain MRI findings for MBD is a crucial step in disease identification.

Keywords: Drugs misuse (including addiction); Medical management; Neuroimaging; Neurology (drugs and medicines).

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Restricted diffusion in the parieto-occipital lobes (left, red arrows), comparing to T2-FLAIR image (right).
Figure 2
Figure 2
(A) Axial view of diffusion-weighted imaging (DWI) with hyperintensity, indicating diffusion restriction. (B) Axial view of apparent diffusion coefficient sequence with hypointensity, indicating diffusion restriction. (C) Axial view of T2- FLAIR axial which does not show any chronic cytotoxic or vasogenic oedema. (D) Axial view of intact hypothalamus (red arrow). (E, F) Axial views of both DWI and T2-FLAIR view of the pons, no acute lesions are seen.

References

    1. Tian TY, Pescador Ruschel MA, Park S, et al. . Marchiafava Bignami Disease 2021. - PubMed
    1. Muccio CF, De Lipsis L, Belmonte R, et al. . Reversible MR findings in Marchiafava-Bignami disease. Case Rep Neurol Med 2019;2019:1–3. 10.1155/2019/1951030 - DOI - PMC - PubMed
    1. Goldstein A, Covington BP, Mahabadi N, et al. . Neuroanatomy. Corpus Callosum 2022. - PubMed
    1. Carrilho PEM, Santos MBMD, Piasecki L, et al. . Marchiafava-Bignami disease: a rare entity with a poor outcome. Rev Bras Ter Intensiva 2013;25:68-72. 10.1590/s0103-507x2013000100013 - DOI - PMC - PubMed
    1. Dong X, Bai C, Nao J. Clinical and radiological features of Marchiafava–Bignami disease. Medicine 2018;97. - PMC - PubMed

Publication types